Hyaluronic Acid Market Analysis Prophesied to Grow at a Faster Pace by 2025
Industry Trends
The industry is witnessing the
implementation by industry players of newer technology and regional expansion
through approvals and mergers and acquisitions. In 2015 OrthogenRx announced
GenVisc 850 FDA approval for patients with OA knee pain. It was developed in
collaboration with Meiji Seika Pharma Co., Ltd. and TedecMeiji Farma S.A. It
has been licensed by Meiji Seika Pharma Group and its partners in 60 countries,
under the name ADANT, outside the USA.
The category of osteoarthritis is
further categorized into5-injection,3-injection, and single injection. Despite
the higher treatment costs relative to its alternatives, single hyaluronic acid
injection is well received by the market for hyaluronic acid. Single-injection
offers greater convenience and reduces hospital visits, while at the same time
reducing pain and adverse effects. Increasing geriatric population and rising
cases of obesity are expected to further expand the market for hyaluronic acid
over the forecast period.
In March 2018, Bioventus launched
a new single-injection joint lubricant, Durolane in U.S for the treatment of
osteoarthritis pain in knee. Bioventus is the company in U.S. with
one-injection (Durolane), three-injection (Gelsyn-3) and five-injection
(Supartz FX) hyaluronic acid option for treating knee osteoarthritis pain.
For More Details Contact Us@ info@gqreports.com
According to the American Society of Plastic Surgeons
(ASAPS), dermal fillers are the most popular and nonsurgical injectable
procedures, especially used for correcting soft tissue defects of the face.
Hyaluronic acid-based dermal fillers are commonly used for aesthetic
procedures, such as improving nasolabial folds, eye wrinkles, dark circles,
scar remediation, and rejuvenation. Hyaluronic acid injections are easy to use,
effective, and relatively less expensive, and these associated advantages are
expected to drive the market for hyaluronic acid during the forecast period.
Global Hyaluronic Acid Market Market Revenue & Forecast, (US$ Million), 2015 – 2027
Some
key industry contributors are: Allergan, Inc.; Galderma; Salix Pharmaceuticals;
Lifecore Biomedical; Anika Therapeutics; Sanofi, Shiseido; Smith and Nephew
Plc; LG Life Sciences; Maruha Nichiro, Inc.; Ferring Pharmaceutical; and
Contipro.
Market
players are involved in R&D activities in order to introduce advanced and
effective products. For instance, Anika Therapeutics, Inc. launched CINGAL in
Europe in 2016. The company intended to make the product available in Germany,
Poland, Italy, Czech Republic, and Hungary.
Hyaluronic
Acid Market in Healthcare Market:
Application
Outlook : Dermal fillers, Osteoarthritis, Single injection, Three injection,
Five injection
Ophthalmic,
Vesicoureteral reflux
By
Geography:
North America: (U.S, Canada, Mexico, Rest of
North America)Europe: (France, The UK, Spain, Germany, Italy)
Nordic
Countries: (Denmark, Finland, Iceland, Sweden, Norway)
Benelux
Union: (Belgium, The Netherlands, Luxembourg, Rest of Europe)
Asia
Pacific:(China, Japan, India, New Zealand, Australia, South Korea)
Southeast
Asia: (Indonesia, Thailand, Singapore)
Rest of
Southeast Asia
Middle
East and Africa: (Saudi Arabia, UAE, Egypt, South Africa, Rest of Middle East
and Africa)
Latin
America: (Brazil, Argentina, Rest of Latina America)
For TOC and Reports
Related Enquiry Mail Us@ sales@gqreports.com
About Us:
GQ Market Reports is a company that is creating cutting
edge, futuristic and informative reports in many different areas. Some of the
most common areas where we generate reports are industry reports, country
reports, company reports and everything in between. At Si market research, we
give our clients the best reports that can be made in the market. Our reports
are not only about market statistics, but they also contain a lot of
information about new and niche company profiles.
Contact
Details:
+91 92843 95731
Comments
Post a Comment